Holen Sie sich die Stockscreener-App
3.61
7.44%
-0.29
Perspective Therapeutics Inc Aktie (CATX) Neueste Nachrichten
Does Perspective Therapeutics Inc. fit your quant trading modelPortfolio Risk Summary & Real-Time Chart Pattern Alerts - Newser
Volume spikes in Perspective Therapeutics Inc. stock – what they meanDividend Hike & Safe Capital Growth Stock Tips - Newser
What technical models suggest about Perspective Therapeutics Inc.’s comebackPortfolio Update Report & High Yield Stock Recommendations - Newser
How Perspective Therapeutics Inc. stock performs during market volatilityCPI Data & Stock Market Timing Techniques - Newser
Can Perspective Therapeutics Inc. hit a new high this monthCEO Change & Free Community Consensus Stock Picks - Newser
How to read the order book for Perspective Therapeutics Inc.July 2025 Weekly Recap & Reliable Intraday Trade Plans - Newser
Perspective Therapeutics price target raised to $16 from $15 at RBC Capital - MSN
Short Interest Drops in Perspective Therapeutics Inc. After RallyMarket Movers & Target Return Focused Stock Picks - sundaytimes.kr
Perspective Therapeutics: Q2 Earnings Snapshot - Greenwich Time
Perspective Therapeutics Reports Promising Study Results at ASCO - TipRanks
Perspective Therapeutics Posts Q2 2025 Earnings, Highlights Clinical Progress and Financial Stability - AInvest
Perspective Therapeutics Reports Q2 2025 Progress and Financials - TipRanks
Oppenheimer lowers Perspective Therapeutics stock price target to $14 - Investing.com India
Gain Therapeutics, Inc. shares rise 3.27% intraday after Perspective Therapeutics presented positive [212Pb]VMT-α-NET study update at ASCO Annual Meeting. - AInvest
Perspective Therapeutics: Navigating the Theranostics Frontier with Precision and Purpose - AInvest
Perspective Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 - MarketScreener
Perspective Therapeutics Q2 Loss: $21.5M, Aligns with ForecastNews and Statistics - IndexBox
Perspective Therapeutics earnings matched, revenue topped estimates By Investing.com - Investing.com Canada
Perspective Therapeutics Inc (CATX) Q2 2025 Earnings: EPS Loss o - GuruFocus
Perspective Therapeutics Reports Q2 Loss - AOL.com
Perspective Therapeutics Provides Recent Business Highlights and Reports 2Q 2025 Results - The Globe and Mail
CATX 8-K: Q2 2025 results released; corporate deck updated - Stock Titan
Cancer Drug Developer Perspective Sees Treatment Success: 4 of 7 Patients Respond in Phase 1/2a Trial - Stock Titan
What to do if you’re stuck in Perspective Therapeutics Inc.2025 Volume Leaders & AI Powered Trade Plan Recommendations - Newser
Perspective Therapeutics Q2 Earnings Preview: Analysts Expect Losses and Revenue Decline - AInvest
What makes Perspective Therapeutics Inc. stock price move sharplyFree Trend Analysis for Safer Trades - Newser
Multi factor analysis applied to Perspective Therapeutics Inc.Free Value Investing Picks With Stability - Newser
Perspective Therapeutics (CATX) Projected to Post Earnings on Wednesday - Defense World
Perspective Therapeutics, Inc. (NYSE:CATX) Receives Consensus Recommendation of “Buy” from Analysts - Defense World
Ranking Perspective Therapeutics Inc. among high performing stocks via toolsFree Risk Controlled Short Term Trade Plans - Newser
Perspective Therapeutics, Inc. shares rise 3.09% after-hours following a corporate update on clinical progress and strategic positioning. - AInvest
Published on: 2025-08-04 12:18:12 - Jammu Links News
When is Perspective Therapeutics Inc. stock expected to show significant growthInvest smarter with expert stock recommendations - Jammu Links News
Why is Perspective Therapeutics Inc. stock attracting strong analyst attentionConsistent triple returns - Jammu Links News
What are the technical indicators suggesting about Perspective Therapeutics Inc.Unlock your portfolio’s hidden potential - Jammu Links News
How does Perspective Therapeutics Inc. generate profit in a changing economyBuild wealth steadily with proven methods - Jammu Links News
What are the latest earnings results for Perspective Therapeutics Inc.Unlock rapid growth potential in your portfolio - Jammu Links News
How many analysts rate Perspective Therapeutics Inc. as a “Buy”Build a strong portfolio for long-term success - Jammu Links News
Perspective Therapeutics: Giving Us Some Valuable Perspective On Alpha Emitter Therapy - Seeking Alpha
Perspective Therapeutics (NYSE:CATX) vs. Motus GI (NASDAQ:MOTS) Critical Contrast - Defense World
Perspective Therapeutics Updates Radiopharmaceutical Platform Presentation - TipRanks
Live market analysis of Perspective Therapeutics Inc.Predictive AI Engine for Smart Investing - Newser
Applying chart zones and confluence areas to Perspective Therapeutics Inc.Short-Term AI-Based Stock Price Forecast - Newser
When is the best time to exit Perspective Therapeutics Inc.Smart Trade Mapping with Entry Details - Newser
How strong is Perspective Therapeutics Inc. company’s balance sheetTop Growth Tips For Consistent Profits - jammulinksnews.com
Analysts Are Bullish on These Healthcare Stocks: Aclaris Therapeutics (ACRS), Nuvation Bio (NUVB) - The Globe and Mail
Perspective Therapeutics Inc. Earnings Report Breakdown: What Investors Should KnowAI Driven Buy Alert Trade Blueprint Released - metal.it
Is It Too Late to Sell Perspective Therapeutics Inc.Watchlist for Smart Swing Trading Updated - metal.it
1.74%
0.24%
Kapitalisierung:
|
Volumen (24h):